(Q73589021)

English

c-erbB-2 positivity is a factor for poor prognosis in breast cancer and poor response to hormonal or chemotherapy treatment in advanced disease

scientific article published on 01 February 2001

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11239756%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

c-erbB-2 positivity is a factor for poor prognosis in breast cancer and poor response to hormonal or chemotherapy treatment in advanced disease (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11239756%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

A Jukkola

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11239756%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

R Bloigu

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11239756%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

Y Soini

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11239756%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

E R Savolainen

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11239756%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

K Holli

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11239756%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

G Blanco

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11239756%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

publication date

1 February 2001

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11239756%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

European Journal of Cancer

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11239756%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

37

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11239756%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11239756%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

347-354

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11239756%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

Tyrosine kinase receptor with extensive homology to EGF receptor shares chromosomal location with neu oncogene

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900395-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Overexpression of the EGF receptor-related proto-oncogene erbB-2 in human mammary tumor cell lines by different molecular mechanisms

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900395-6

7 January 2021

based on heuristic

inferred from DOI database lookup

erbB-2 is a potent oncogene when overexpressed in NIH/3T3 cells

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900395-6

7 January 2021

based on heuristic

inferred from DOI database lookup

The relationship between c-erbB-2 expression, S-phase fraction and prognosis in breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900395-6

7 January 2021

based on heuristic

inferred from DOI database lookup

erbB-2, p53, and efficacy of adjuvant therapy in lymph node-positive breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900395-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Association of c-erbB-2 protein over-expression with high rate of cell proliferation, increased risk of visceral metastasis and poor long-term survival in breast cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900395-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Elevated serum c-erbB-2 antigen levels and decreased response to hormone therapy of breast cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900395-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Prediction of response to antiestrogen therapy in advanced breast cancer patients by pretreatment circulating levels of extracellular domain of the HER-2/c-neu protein

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900395-6

7 January 2021

based on heuristic

inferred from DOI database lookup

c-erb B2 overexpression decreases the benefit of adjuvant tamoxifen in early-stage breast cancer without axillary lymph node metastases

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900395-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Prognostic importance of c-erbB-2 expression in breast cancer. International (Ludwig) Breast Cancer Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900395-6

7 January 2021

based on heuristic

inferred from DOI database lookup

HER-2/neu in node-negative breast cancer: prognostic significance of overexpression influenced by the presence of in situ carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900395-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Independent Prognostic Factors in Breast Cancer Patients

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900395-6

7 January 2021

based on heuristic

inferred from DOI database lookup

No significant predictive value of c-erbB-2 or p53 expression regarding sensitivity to primary chemotherapy or radiotherapy in breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900395-6

7 January 2021

based on heuristic

inferred from DOI database lookup

c-erbB-2 expression and response to adjuvant therapy in women with node-positive early breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900395-6

7 January 2021

based on heuristic

inferred from DOI database lookup

erbB-2 and response to doxorubicin in patients with axillary lymph node-positive, hormone receptor-negative breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900395-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900395-6

7 January 2021

based on heuristic

inferred from DOI database lookup

The neu oncogene encodes an epidermal growth factor receptor-related protein

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900395-6

7 January 2021

based on heuristic

inferred from DOI database lookup

c-erbB2 expression in correlation to other biological parameters of breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900395-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Correlation between histologic grade of malignancy and copy number of c-erbB-2 gene in breast carcinoma. A retrospective analysis of 176 cases

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900395-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900395-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Expression of ras p21, p53 and c-erbB-2 in advanced breast cancer and response to first line hormonal therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900395-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0959-8049(00)00395-6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11239756%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11239756%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q73589021&oldid=1966915439"